Varian

CTSI Oncology Solutions, a Varian company, entered a multi-year agreement with CHRISTUS Health to provide technology-enabled services for radiation oncology at six CHRISTUS departments, including software platforms and new linear accelerators.

Siemens Healthineers announced it will purchase all shares of Varian Medical Systems for $177.50 per share in cash, a total of $16.4 billion. The merger aims to create a global leader in cancer care, with Varian retaining its brand. The transaction is expected to close in the first half of 2021.

Varian signed an agreement with Massachusetts General Hospital to provide seven Varian radiotherapy systems and related services for advanced cancer treatment. Installation is expected to begin in late 2020.

Varian acquired privately-held humediQ Global GmbH, manufacturer of the IDENTIFY automated patient identification and motion management system for radiation therapy. Financial terms were not disclosed.